Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ITRACONAZOLE Cause Malignant neoplasm progression? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with ITRACONAZOLE (Itraconazole). This represents 0.2% of all adverse event reports for ITRACONAZOLE.

6
Reports of Malignant neoplasm progression with ITRACONAZOLE
0.2%
of all ITRACONAZOLE reports
5
Deaths
3
Hospitalizations

How Dangerous Is Malignant neoplasm progression From ITRACONAZOLE?

Of the 6 reports, 5 (83.3%) resulted in death, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ITRACONAZOLE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does ITRACONAZOLE Cause?

Drug ineffective (560) Drug interaction (418) Off label use (268) Condition aggravated (193) Dyspnoea (188) Nausea (153) Drug resistance (152) Rash (125) Hypertension (117) Diarrhoea (114)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which ITRACONAZOLE Alternatives Have Lower Malignant neoplasm progression Risk?

ITRACONAZOLE vs ITRACONAZOLE\SODIUM ITRACONAZOLE vs IVABRADINE ITRACONAZOLE vs IVACAFTOR ITRACONAZOLE vs IVACAFTOR\LUMACAFTOR ITRACONAZOLE vs IVACAFTOR\TEZACAFTOR

Related Pages

ITRACONAZOLE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression ITRACONAZOLE Demographics